Yan Kaijing and Li Yunhui signed an agreement to acquire 11% stake in Tasly Pharmaceutical Group Co., Ltd. (SHSE:600535) from Yan Xijun and Wu Nai Feng for CNY 4 million on March 27, 2016. Under the terms of the deal, Yan Xijun plans to transfer 5% stake to Yan Kaijing for CNY 1.8 million and Wu Nai Feng plans to transfer 6% stake to Li Yunhui for CNY 2.16 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.35 CNY | 0.00% | -4.97% | -15.69% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.69% | 2.96B | |
+37.65% | 6.04B | |
-19.68% | 4.27B | |
+4.49% | 3.28B | |
-5.64% | 2.43B | |
+44.89% | 1.93B | |
-12.71% | 1.59B | |
-4.27% | 1.58B | |
-14.86% | 1.5B | |
+42.40% | 1.47B |
- Stock Market
- Equities
- 600535 Stock
- News Tasly Pharmaceutical Group Co., Ltd
- Yan Kaijing and Li Yunhui signed an agreement to acquire 11% stake in Tasly Pharmaceutical Group Co., Ltd. from Yan Xijun and Wu Nai Feng for CNY 4 million.